EICHOR
● Completed
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Condition: Growth Hormone Deficiency (GHD) · Sponsor: Ascendis Pharma A/S
About this study
A six month study of ACP-001, a long-acting growth hormone product, versus standard human growth hormone therapy. ACP-001 will be given once-a-week, standard human growth hormone (hGH) will be given on a daily basis. The primary aim is to demonstrate safety, pharmacokinetics and pharmacodynamics over a period of six months. A secondary objective is the comparison of height velocity (HV) of the ACP-001 treated groups to the daily hGH treatment group.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (36)
| 2nd Children City Clinic | Minsk, Belarus | — |
| University Multiprofile Hospital for Active Treatment (UMHAT) "Sv. Marina" | Varna, Bulgaria | — |
| Masaryk´s Hospital | Ústí nad Labem, Czechia | — |
| El Shatby University Hospital | Alexandria, Egypt | — |
| Ain Shams University Hospital | Cairo, Egypt | — |
| Cairo University Hospital | Cairo, Egypt | — |
| El Mansoura University Hospital | El Mansoura, Egypt | — |
| Hôpital des enfants Pellegrin | Bordeaux, France | — |
| Hôpital Jeanne de Flandre | Lille, France | — |
| Hôpital Femme-Mère-Enfant | Lyon, France | — |
| University Hospital Leipzig | Leipzig, Germany | — |
| University Children's Hospital Magdeburg | Magdeburg, Germany | — |
+ 24 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01947907